Abstract
Insulin's molecular structure consists of two peptide chains linked by disulfide bonds, forming a biologically active monomer that can polymerize into hexamers for storage. Variations from analogs provide modifications in pharmacokinetic properties but retain the core insulin structure.
Keywords
- Pancreatic function and diabetes
- insulin
- molecular structure
- disulfide bonds
- peptide chains
- insulin monomer
- insulin hexamer
- insulin analogues
- pharmacokinetics
- insulin storage
- Open access
Source
Published in Zenodo (CERN European Organization for Nuclear Research). The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.